Exosome Therapy for Intimate Rejuvenation

Next-generation cellular signalling for intimate tissue regeneration

Exosome therapy represents the next generation of regenerative intimate medicine — using concentrated extracellular vesicles loaded with growth factors, RNA and signalling proteins to direct tissue regeneration in vaginal and vulvar tissues with greater precision than standard PRP.

Exosomes are derived from stem cells and offer a powerful cell-free approach to tissue rejuvenation — stimulating collagen production, improving hydration, enhancing sensation and reversing atrophic changes with minimal injections.

Key Benefits

More concentrated regenerative signalling than standard PRP
Stimulates collagen, hydration and tissue regeneration
Cell-free — no risk of rejection or immune reaction
Fewer sessions needed compared to PRP for equivalent regenerative effect

Is This Treatment Right For You?

Women wanting the most advanced intimate regenerative treatment
Those who have not achieved adequate results with PRP
Post-menopausal patients with significant atrophic changes

What to Expect

Consultation

Suitability and goals assessed by the treating physician.

Exosome Preparation

Certified exosome preparation prepared aseptically.

Injection

Exosomes injected into target vaginal and vulvar tissues under topical anaesthesia.

Follow-Up

Review at 4–6 weeks to assess response and plan further sessions if needed.

Recovery & Aftercare

Minimal — mild soreness for 24–48 hours; sexual activity resumed after 3–5 days.

Frequently Asked Questions

How is exosome therapy different from PRP?

Exosomes contain a more diverse range of regenerative signals than PRP growth factors — they instruct cells rather than simply stimulating them, producing more targeted tissue rejuvenation.

Is exosome therapy approved?

Exosome preparations are manufactured under strict quality controls; they are used in a growing number of licensed clinics as an advanced regenerative treatment under physician supervision.